UBS Group
AIFF

UBS Group’s Firefly Neuroscience AIFF Stock Holding History

UBS Group’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
132,195
+107,490
+435% +$134K ﹤0.01% 6423
2025
Q4 		$21.6K Sell
24,705
-66,015
-73% -$123K ﹤0.01% 7727
2025
Q3 		$264K Sell
90,720
-149,668
-62% -$424K ﹤0.01% 6508
2025
Q2 		$680K Buy
240,388
+146,759
+157% +$465K ﹤0.01% 5761
2025
Q1 		$368K Buy
93,629
+77,157
+468% +$355K ﹤0.01% 6095
2024
Q4 		$43.7K Buy
+16,472
New +$51.1K ﹤0.01% 7387
2024
Q3 		– Sell
-2,308
Closed -$14.3K – 10217
2024
Q2 		$14.3K Buy
2,308
+1,293
+127% +$9.62K ﹤0.01% 7519
2024
Q1 		$10.5K Sell
1,015
-1,197
-54% -$8.03K ﹤0.01% 7223
2023
Q4 		$11.2K Buy
2,212
+1,942
+719% +$12.6K ﹤0.01% 7402
2023
Q3 		$2.1K Buy
+270
New +$2.77K ﹤0.01% 7769
2023
Q2 		– Hold
0
– – – 9790
2023
Q1 		– Sell
-625
Closed -$8.99K – 10541
2022
Q4 		$8.99K Buy
625
+150
+32% +$3.49K ﹤0.01% 8702
2022
Q3 		$14K Buy
475
+259
+120% +$9.5K ﹤0.01% 7937
2022
Q2 		$8K Buy
216
+203
+1,562% +$19.6K ﹤0.01% 8370
2022
Q1 		$2K Sell
13
-9
-41% -$1.22K ﹤0.01% 9686
2021
Q4 		$3K Buy
+22
New +$2.63K ﹤0.01% 9703

Other funds holding AIFF

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group's AIFF Position: Q1 2026 in Review

UBS Group increased its Firefly Neuroscience (AIFF) stake by 435% in Q1 2026, buying an estimated $134K and bringing the position to 132,195 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #6423.

UBS Group first reported a position in AIFF in Q4 2021 and has held it in 15 quarters since. The position peaked at $680K in Q2 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • UBS Group held 132,195 shares of Firefly Neuroscience worth $288K as of Q1 2026.
  • UBS Group bought 107,490 Firefly Neuroscience shares in Q1 2026, an estimated $134K.
  • Firefly Neuroscience made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6423 holding.
  • UBS Group first reported a position in Firefly Neuroscience in Q4 2021 and has held it in 15 quarters since.
  • UBS Group's Firefly Neuroscience position peaked at $680K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.